Cheminformatic Tools and Databases for Pharmacology

session 36026 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
FIDAXOMICIN (has an active metabolite)

FIDAXOMICIN


ATC A07AA12

ANTIINFECTIVES
MACROLIDE
TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA
INHIBITOR RNA SYNTHESIS BY RNA POLYMERASES

ORAL

Cmax 4.9 NANOMOLAR (200 MILLIGRAM)

Tmax 2 HOUR

HT 11.7 HOUR

BETA SUBUNIT OF RNA POLYMERASE

PDB 6BZO (MTB RNAP HOLO, RBPA, FIDAXOMICIN, UPSTREAM FORK DNA)

LIGAND CODE = FI8 (link to the list of PDB complexes)

Download experimental 3D coordinates of FI8 with added hydrogens

DNA-directed RNA polymerase UNIPROT Q182S6 rpoZ

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M FIDAXOMICIN (is an active metabolite)

FIDAXOMICIN


ATC A07AA12

ANTIINFECTIVES
MACROLIDE
TREATMENT OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA
INHIBITOR RNA SYNTHESIS BY RNA POLYMERASES

-

Cmax 12.1 NANOMOLAR (200 MILLIGRAM)

Tmax 1.02 HOUR

HT 11.2 HOUR

BETA SUBUNIT OF RNA POLYMERASE

DNA-directed RNA polymerase UNIPROT Q182S6 rpoZ

more at DrugCentral

EMA

ANSM (in French)

Inxight Drugs
Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |